department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

LAMOTRIGINE · pharmadog

pharmadog
drugs
LAMOTRIGINE

drug

patient view →

LAMOTRIGINE

Marketedupdated 2mo ago

by Ipca Pharmaceuticals Inc

Approved

community read0 votes

indications

investigational

Epilepsy

all catalysts(100)

approval · 100

LAMICTAL (LAMOTRIGINE) — FDA approval

LAMICTAL (LAMOTRIGINE) — FDA approval

LAMICTAL (LAMOTRIGINE) — FDA approval

LAMICTAL (LAMOTRIGINE) — FDA approval

LAMICTAL (LAMOTRIGINE) — FDA approval

LAMICTAL CD (LAMOTRIGINE) — FDA approval

LAMICTAL CD (LAMOTRIGINE) — FDA approval

LAMICTAL (LAMOTRIGINE) — FDA approval

LAMICTAL (LAMOTRIGINE) — FDA approval

LAMICTAL (LAMOTRIGINE) — FDA approval

LAMICTAL CD (LAMOTRIGINE) — FDA approval

LAMICTAL (LAMOTRIGINE) — FDA approval

LAMICTAL (LAMOTRIGINE) — FDA approval

LAMICTAL CD (LAMOTRIGINE) — FDA approval

view all 100 catalysts →

News(0)

no news has mentioned this drug yet

brand

LAMOTRIGINE

generic

LAMOTRIGINE

indication

Bipolar Disorder (Manic Depression)

phase

marketed

LAMICTAL CD (LAMOTRIGINE) — FDA approval

LAMICTAL (LAMOTRIGINE) — FDA approval

LAMICTAL CD (LAMOTRIGINE) — FDA approval

LAMICTAL (LAMOTRIGINE) — FDA approval

LAMICTAL CD (LAMOTRIGINE) — FDA approval

LAMICTAL (LAMOTRIGINE) — FDA approval

LAMICTAL (LAMOTRIGINE) — FDA approval

LAMICTAL (LAMOTRIGINE) — FDA approval

LAMICTAL CD (LAMOTRIGINE) — FDA approval

LAMICTAL (LAMOTRIGINE) — FDA approval

LAMICTAL CD (LAMOTRIGINE) — FDA approval

LAMICTAL (LAMOTRIGINE) — FDA approval

LAMICTAL CD (LAMOTRIGINE) — FDA approval

LAMICTAL (LAMOTRIGINE) — FDA approval

LAMICTAL CD (LAMOTRIGINE) — FDA approval

LAMICTAL CD (LAMOTRIGINE) — FDA approval

LAMICTAL (LAMOTRIGINE) — FDA approval

LAMICTAL CD (LAMOTRIGINE) — FDA approval

LAMICTAL CD (LAMOTRIGINE) — FDA approval

LAMICTAL (LAMOTRIGINE) — FDA approval

LAMICTAL (LAMOTRIGINE) — FDA approval

LAMICTAL (LAMOTRIGINE) — FDA approval

LAMICTAL CD (LAMOTRIGINE) — FDA approval

LAMOTRIGINE — FDA approval

LAMOTRIGINE — FDA approval

LAMOTRIGINE — FDA approval

LAMOTRIGINE — FDA approval

LAMICTAL (LAMOTRIGINE) — FDA approval

LAMICTAL CD (LAMOTRIGINE) — FDA approval

LAMICTAL CD (LAMOTRIGINE) — FDA approval

LAMICTAL (LAMOTRIGINE) — FDA approval

LAMICTAL (LAMOTRIGINE) — FDA approval

LAMICTAL CD (LAMOTRIGINE) — FDA approval

LAMICTAL ODT (LAMOTRIGINE) — FDA approval

LAMICTAL XR (LAMOTRIGINE) — FDA approval

LAMOTRIGINE — FDA approval

LAMOTRIGINE — FDA approval

LAMOTRIGINE — FDA approval

LAMOTRIGINE — FDA approval

LAMOTRIGINE — FDA approval

LAMOTRIGINE — FDA approval

LAMICTAL XR (LAMOTRIGINE) — FDA approval

LAMICTAL XR (LAMOTRIGINE) — FDA approval

LAMOTRIGINE — FDA approval

LAMOTRIGINE — FDA approval

LAMOTRIGINE — FDA approval

LAMOTRIGINE — FDA approval

LAMOTRIGINE — FDA approval

LAMOTRIGINE — FDA approval

LAMOTRIGINE — FDA approval

LAMICTAL XR (LAMOTRIGINE) — FDA approval

LAMICTAL ODT (LAMOTRIGINE) — FDA approval

LAMICTAL XR (LAMOTRIGINE) — FDA approval

LAMICTAL CD (LAMOTRIGINE) — FDA approval

LAMICTAL ODT (LAMOTRIGINE) — FDA approval

LAMICTAL (LAMOTRIGINE) — FDA approval

LAMICTAL (LAMOTRIGINE) — FDA approval

LAMICTAL CD (LAMOTRIGINE) — FDA approval

LAMOTRIGINE — FDA approval

LAMICTAL XR (LAMOTRIGINE) — FDA approval

LAMOTRIGINE — FDA approval

LAMICTAL CD (LAMOTRIGINE) — FDA approval

LAMICTAL (LAMOTRIGINE) — FDA approval

LAMICTAL ODT (LAMOTRIGINE) — FDA approval

LAMICTAL XR (LAMOTRIGINE) — FDA approval

LAMICTAL ODT (LAMOTRIGINE) — FDA approval

LAMICTAL (LAMOTRIGINE) — FDA approval

LAMICTAL CD (LAMOTRIGINE) — FDA approval

LAMICTAL XR (LAMOTRIGINE) — FDA approval

LAMOTRIGINE — FDA approval

LAMOTRIGINE — FDA approval

LAMOTRIGINE — FDA approval

LAMICTAL XR (LAMOTRIGINE) — FDA approval

LAMICTAL ODT (LAMOTRIGINE) — FDA approval

LAMICTAL CD (LAMOTRIGINE) — FDA approval

LAMICTAL (LAMOTRIGINE) — FDA approval

LAMOTRIGINE — FDA approval

LAMOTRIGINE — FDA approval

LAMOTRIGINE — FDA approval

LAMOTRIGINE — FDA approval

LAMOTRIGINE — FDA approval

LAMOTRIGINE — FDA approval

LAMOTRIGINE — FDA approval

LAMOTRIGINE — FDA approval

LAMOTRIGINE — FDA approval

LAMOTRIGINE — FDA approval

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Patent cliff

source: FDA Orange Book

first barrier falls

Jan 7, 2029

~2.5 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (8)

May 29, 2040method-of-use (U-4273)US 11596634
May 29, 2040method-of-use (U-4273)US 11612566
Jan 7, 2029formulationUS 86375122.5y
Jan 7, 2029formulationUS 86375122.5y
Jan 7, 2029formulationUS 86375122.5y
Jan 7, 2029formulationUS 86375122.5y
Jan 7, 2029formulationUS 86375122.5y
Jan 7, 2029formulationUS 86375122.5y

Data sources

openFDA · ClinicalTrials.gov

last refreshed 31m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

Trials studying LAMOTRIGINE

phase3A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)recruitingn=450
phase1A Study to Evaluate the Effects of Lithium, Valproic Acid, and Lamotrigine on the Pharmacokinetics of KarXT and Effects of KarXT on the Pharmacokinetics of Lithium, Valproic Acid, and Lamotrigine in Healthy Participantscompletedn=133
phase1Lamotrigine 25 mg Chewable Tablets, Non-Fastingcompletedn=32
phase1Bioequivalence Study of 200 mg Lamotrigine Tablet Under Fasting Conditionscompletedn=32
phase1Bioequivalence Study of 200 mg Lamotrigine Tablet Under Non-Fasting Conditionscompletedn=32
phase1Lamotrigine 25 mg Chewable Tablets, Fastingcompletedn=32
phase1Fasting Study of Lamotrigine Tablets 25 mg to Lamictal® Tablets 25 mgcompletedn=27
phase1Food Study of Lamotrigine Tablets 25 mg to Lamictal® Tablets 25 mgcompletedn=28

more trials →